Cardiac dysfunction 是什么意思，中文意思 | 心功能障碍英文怎么说医学英语中英文词汇翻译

Cardiac Dysfunction and Noncardiac Dysfunction as Precursors of Heart Failure With Reduced and Preserved Ejection Fraction in the CommunityClinical Perspective

CSP Lam, A Lyass, E Kraigher-Krainer… - Circulation, 2011 - Am Heart Assoc
From the National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham,
MA (CSL, AL, JM, DSL, JEH, DL, EJB, RSV); Department of Mathematics and Statistics, Boston
University, Boston, MA (AL); Department of Cardiology, University of Graz, Graz, Austria ...
Cited by 2 - Related articles - All 3 versions

Delta-Sarcoglycan Gene Therapy Halts Progression of Cardiac Dysfunction, Improves Respiratory Failure, and Prolongs Life in Myopathic HamstersClinical …

M Hoshijima, T Hayashi, YE Jeon, Z Fu… - Circulation: Heart …, 2011 - Am Heart Assoc
Methods and Results— We treated 4-month-old BIO14.6 hamsters with established cardiac and
skeletal muscle diseases intravenously with a serotype-9 adeno–associated viral vector carrying
δSG alone or in combination with S16EPLN. Before treatment at age 14 weeks, the left ...
Cited by 1 - Related articles - All 3 versions

Increased CD36 expression in middle-aged mice contributes to obesity-related cardiac hypertrophy in the absence of cardiac dysfunction

MMY Sung, DPY Koonen, CLM Soltys… - Journal of molecular …, 2011 - Springer
Abstract As aging is a significant risk factor for the development of left ventricular
hypertrophy and cardiovascular disease, we hypothesized that hearts from middle-aged
mice may be more sensitive to the effects of a high fat (HF) diet than hearts from young ...
Cited by 1 - Related articles - All 4 versions

Electrocardiographic abnormalities in very young Duchenne muscular dystrophy patients precede the onset of cardiac dysfunction

J James, K Kinnett, Y Wang, RF Ittenbach… - Neuromuscular …, 2011 - Elsevier
Overt cardiac involvement in Duchenne muscular dystrophy (DMD) typically occurs later in the
disease. The primary aim was to estimate the proportion of young (<6 years of age) DMD patients
with manifestations of cardiac disease by electrocardiography (ECG). Secondary aims ...
Related articles - All 3 versions

[HTML] Cardiac Dysfunction after Cancer Treatment

[HTML] from nih.govMS Ewer, SM Swain, D Cardinale… - Texas Heart Institute …, 2011 - ncbi.nlm.nih.gov
The recognition of cardiac dysfunction as a consequence of cancer treatment was much simpler
when anthracycline cardiotoxicity was the dominant concern. We knew of the cumulative dose
relationship as it applied to cardiac dysfunction; we knew that anthracyclines caused cell ...
Related articles - All 2 versions

Cardiac Dysfunction and Noncardiac Dysfunction as Precursors of Heart Failure With Reduced and Preserved Ejection Fraction in the CommunityClinical Perspective

CSP Lam, A Lyass, E Kraigher-Krainer… - Circulation, 2011 - Am Heart Assoc
From the National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham,
MA (CSL, AL, JM, DSL, JEH, DL, EJB, RSV); Department of Mathematics and Statistics, Boston
University, Boston, MA (AL); Department of Cardiology, University of Graz, Graz, Austria ...
Cited by 2 - Related articles - All 3 versions

Delta-Sarcoglycan Gene Therapy Halts Progression of Cardiac Dysfunction, Improves Respiratory Failure, and Prolongs Life in Myopathic HamstersClinical …

M Hoshijima, T Hayashi, YE Jeon, Z Fu… - Circulation: Heart …, 2011 - Am Heart Assoc
Methods and Results— We treated 4-month-old BIO14.6 hamsters with established cardiac and
skeletal muscle diseases intravenously with a serotype-9 adeno–associated viral vector carrying
δSG alone or in combination with S16EPLN. Before treatment at age 14 weeks, the left ...
Cited by 1 - Related articles - All 3 versions

Increased CD36 expression in middle-aged mice contributes to obesity-related cardiac hypertrophy in the absence of cardiac dysfunction

MMY Sung, DPY Koonen, CLM Soltys… - Journal of molecular …, 2011 - Springer
Abstract As aging is a significant risk factor for the development of left ventricular
hypertrophy and cardiovascular disease, we hypothesized that hearts from middle-aged
mice may be more sensitive to the effects of a high fat (HF) diet than hearts from young ...
Cited by 1 - Related articles - All 4 versions

Electrocardiographic abnormalities in very young Duchenne muscular dystrophy patients precede the onset of cardiac dysfunction

J James, K Kinnett, Y Wang, RF Ittenbach… - Neuromuscular …, 2011 - Elsevier
Overt cardiac involvement in Duchenne muscular dystrophy (DMD) typically occurs later in the
disease. The primary aim was to estimate the proportion of young (<6 years of age) DMD patients
with manifestations of cardiac disease by electrocardiography (ECG). Secondary aims ...
Related articles - All 3 versions

[HTML] Cardiac Dysfunction after Cancer Treatment

[HTML] from nih.govMS Ewer, SM Swain, D Cardinale… - Texas Heart Institute …, 2011 - ncbi.nlm.nih.gov
The recognition of cardiac dysfunction as a consequence of cancer treatment was much simpler
when anthracycline cardiotoxicity was the dominant concern. We knew of the cumulative dose
relationship as it applied to cardiac dysfunction; we knew that anthracyclines caused cell ...
Related articles - All 2 versions

Cardiac Dysfunction and Noncardiac Dysfunction as Precursors of Heart Failure With Reduced and Preserved Ejection Fraction in the CommunityClinical Perspective

CSP Lam, A Lyass, E Kraigher-Krainer… - Circulation, 2011 - Am Heart Assoc
From the National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham,
MA (CSL, AL, JM, DSL, JEH, DL, EJB, RSV); Department of Mathematics and Statistics, Boston
University, Boston, MA (AL); Department of Cardiology, University of Graz, Graz, Austria ...
Cited by 2 - Related articles - All 3 versions

Delta-Sarcoglycan Gene Therapy Halts Progression of Cardiac Dysfunction, Improves Respiratory Failure, and Prolongs Life in Myopathic HamstersClinical …

M Hoshijima, T Hayashi, YE Jeon, Z Fu… - Circulation: Heart …, 2011 - Am Heart Assoc
Methods and Results— We treated 4-month-old BIO14.6 hamsters with established cardiac and
skeletal muscle diseases intravenously with a serotype-9 adeno–associated viral vector carrying
δSG alone or in combination with S16EPLN. Before treatment at age 14 weeks, the left ...
Cited by 1 - Related articles - All 3 versions

Increased CD36 expression in middle-aged mice contributes to obesity-related cardiac hypertrophy in the absence of cardiac dysfunction

MMY Sung, DPY Koonen, CLM Soltys… - Journal of molecular …, 2011 - Springer
Abstract As aging is a significant risk factor for the development of left ventricular
hypertrophy and cardiovascular disease, we hypothesized that hearts from middle-aged
mice may be more sensitive to the effects of a high fat (HF) diet than hearts from young ...
Cited by 1 - Related articles - All 4 versions

Electrocardiographic abnormalities in very young Duchenne muscular dystrophy patients precede the onset of cardiac dysfunction

J James, K Kinnett, Y Wang, RF Ittenbach… - Neuromuscular …, 2011 - Elsevier
Overt cardiac involvement in Duchenne muscular dystrophy (DMD) typically occurs later in the
disease. The primary aim was to estimate the proportion of young (<6 years of age) DMD patients
with manifestations of cardiac disease by electrocardiography (ECG). Secondary aims ...
Related articles - All 3 versions

[HTML] Cardiac Dysfunction after Cancer Treatment

[HTML] from nih.govMS Ewer, SM Swain, D Cardinale… - Texas Heart Institute …, 2011 - ncbi.nlm.nih.gov
The recognition of cardiac dysfunction as a consequence of cancer treatment was much simpler
when anthracycline cardiotoxicity was the dominant concern. We knew of the cumulative dose
relationship as it applied to cardiac dysfunction; we knew that anthracyclines caused cell ...
Related articles - All 2 versions

Cardiac Dysfunction and Noncardiac Dysfunction as Precursors of Heart Failure With Reduced and Preserved Ejection Fraction in the CommunityClinical Perspective

CSP Lam, A Lyass, E Kraigher-Krainer… - Circulation, 2011 - Am Heart Assoc
From the National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham,
MA (CSL, AL, JM, DSL, JEH, DL, EJB, RSV); Department of Mathematics and Statistics, Boston
University, Boston, MA (AL); Department of Cardiology, University of Graz, Graz, Austria ...
Cited by 2 - Related articles - All 3 versions

Delta-Sarcoglycan Gene Therapy Halts Progression of Cardiac Dysfunction, Improves Respiratory Failure, and Prolongs Life in Myopathic HamstersClinical …

M Hoshijima, T Hayashi, YE Jeon, Z Fu… - Circulation: Heart …, 2011 - Am Heart Assoc
Methods and Results— We treated 4-month-old BIO14.6 hamsters with established cardiac and
skeletal muscle diseases intravenously with a serotype-9 adeno–associated viral vector carrying
δSG alone or in combination with S16EPLN. Before treatment at age 14 weeks, the left ...
Cited by 1 - Related articles - All 3 versions

Increased CD36 expression in middle-aged mice contributes to obesity-related cardiac hypertrophy in the absence of cardiac dysfunction

MMY Sung, DPY Koonen, CLM Soltys… - Journal of molecular …, 2011 - Springer
Abstract As aging is a significant risk factor for the development of left ventricular
hypertrophy and cardiovascular disease, we hypothesized that hearts from middle-aged
mice may be more sensitive to the effects of a high fat (HF) diet than hearts from young ...
Cited by 1 - Related articles - All 4 versions

Electrocardiographic abnormalities in very young Duchenne muscular dystrophy patients precede the onset of cardiac dysfunction

J James, K Kinnett, Y Wang, RF Ittenbach… - Neuromuscular …, 2011 - Elsevier
Overt cardiac involvement in Duchenne muscular dystrophy (DMD) typically occurs later in the
disease. The primary aim was to estimate the proportion of young (<6 years of age) DMD patients
with manifestations of cardiac disease by electrocardiography (ECG). Secondary aims ...
Related articles - All 3 versions

[HTML] Cardiac Dysfunction after Cancer Treatment

[HTML] from nih.govMS Ewer, SM Swain, D Cardinale… - Texas Heart Institute …, 2011 - ncbi.nlm.nih.gov
The recognition of cardiac dysfunction as a consequence of cancer treatment was much simpler
when anthracycline cardiotoxicity was the dominant concern. We knew of the cumulative dose
relationship as it applied to cardiac dysfunction; we knew that anthracyclines caused cell ...
Related articles - All 2 versions

美国ACCDON公司旗下品牌

[HTML] Cardiac Dysfunction after Cancer Treatment

[HTML] Cardiac Dysfunction after Cancer Treatment

[HTML] Cardiac Dysfunction after Cancer Treatment

[HTML] Cardiac Dysfunction after Cancer Treatment